Flare Therapeutics
Trailblazing the path to drugging transcription factors to discover precision medicines for cancer & other disease areas
62 employees · est. 2021 · Cambridge, United States
Kronos Bio
We’re focused on creating a world where no life is cut short by cancer or other serious diseases.
70 employees · est. 2017 · San Mateo, United States
Kronos Bio is the older company (2021 vs 2017).
Side-by-Side Comparison
| Metric | Flare Therapeutics | Kronos Bio |
|---|---|---|
| Founded | ||
| Founded | 2021 | 2017 older |
| Headquarters | ||
| Headquarters | Cambridge, United States | San Mateo, United States |
| Employees | ||
| Employees | 62 | 70 |
| Industry | ||
| Industry | Biopharma, Biotechnology, Health Care | Biotechnology, Health and Wellness |
| Funding Stage | ||
| Funding Stage | Series B | Private Equity |
| Total Funding | ||
| Total Funding | $205.00M | $278.00M |
| Funding Rounds | ||
| Funding Rounds | 2 | 3 |
| Services | ||
| Services | Development of small molecules for cancer treatment, Research and innovation in transcriptional control | Not tracked yet |
| Target Customers | ||
| Target Customers | Medical professionals, Oncology researchers, Healthcare institutions, Patients with cancer | Not tracked yet |
| Taxonomy | ||
| Taxonomy | Precision Medicines, Transcription Factors, Oncology, Drug Discovery, Small Molecule Inhibitors, Urothelial Cancer, Androgen Receptor Degrader, Transcription Factor Regulation, Integrated Discovery Platform, Emerging Pipeline, Precision Oncology, Neurology, Rare Genetic Disorders, Immunology, Inflammation | Biopharmaceutical Company, Clinical-stage, Therapeutics, CDK9 Inhibitor, Transcription Factor, Oncology, Cancer Treatment, Myc-dependent Tumors, Transcriptional Addiction, Discovery Collaboration, Genentech Partnership, P300 KAT Domain, Multiple Myeloma, Transcriptional Targets, Precision Medicine |
| Website | ||
| Website | flaretx.com | kronosbio.com |
About Flare Therapeutics
Flare Therapeutics, founded in 2021, is trailblazing the path to drugging transcription factors to discover precision medicines for cancer and other disease areas. This United States-based company is strategically positioned in the biopharma, biotechnology, health care, and life sciences industries....
About Kronos Bio
Kronos Bio is a clinical-stage biopharmaceutical company with a mission to combat cancer and serious diseases by targeting dysregulated transcription. The company's current pipeline includes KB-0742, a CDK9 inhibitor under evaluation for MYC-dependent tumors and KB-9558, targeting the KAT domain of...
We will tell you when either one moves
BounceWatch watches Flare Therapeutics and Kronos Bio for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.
Funding, hiring, leadership and stack changes at Flare Therapeutics and Kronos Bio — by email.
Frequently Asked Questions
Compare Flare Therapeutics with someone else
Start typing a company name or domain.
Related Comparisons
Compiled from the BounceWatch company index. We last looked at Flare Therapeutics on 11 Mar 2026, and Kronos Bio on 12 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.